Clinical Trials Sponsored by Perha Pharmaceuticals
Total 19707 results
-
Regeneron PharmaceuticalsRecruitingMetastatic Castration-resistant Prostate CancerUnited States
-
Regeneron PharmaceuticalsRecruitingChronic Kidney Disease (CKD)United States
-
Arrowhead PharmaceuticalsRecruitingIgA Nephropathy | C3 GlomerulopathyNew Zealand, Australia, Korea, Republic of, Thailand, Germany, United Kingdom, Georgia
-
Regeneron PharmaceuticalsRecruitingGeneralized Myasthenia GravisUnited States, Japan, Spain, Taiwan, Germany, Italy, Canada, Turkey, Georgia, Belgium, India, Poland, Australia, Denmark, France, United Kingdom, Korea, Republic of, Serbia, Czechia
-
Jazz PharmaceuticalsRecruitingExtensive-stage Small-cell Lung CancerUnited States, Canada
-
Syros PharmaceuticalsRecruitingMyelodysplastic SyndromesUnited States, Spain, Belgium, Israel, France, United Kingdom, Austria, Czechia, Italy, Poland, Canada, Hungary, Germany
-
Vanda PharmaceuticalsRecruitingSleep Wake Disorders | Sleep Disorders, Circadian Rhythm | Chronobiology DisordersUnited States, Australia, Germany
-
Jazz PharmaceuticalsRecruitingSeizure in Participants With Tuberous Sclerosis Complex | Seizure in Participants With Dravet Syndrome | Seizure in Participants With Lennox-Gastaut SyndromeUnited States
-
Regeneron PharmaceuticalsRecruitingSquamous Cell Carcinoma of Head and NeckUnited States, Spain
-
ESSA PharmaceuticalsRecruitingProstate CancerUnited States, Canada
-
Constellation PharmaceuticalsRecruitingLymphoma, T-Cell | Mesothelioma, Malignant | Advanced Solid Tumor | Endometrial Cancer | Diffuse Large B Cell Lymphoma | Ovarian Clear Cell Carcinoma | Prostatic Neoplasms, Castration-ResistantUnited States, Korea, Republic of, France, United Kingdom, Italy, Spain, Poland
-
Actinium PharmaceuticalsRecruitingAcute Myeloid Leukemia | Relapsed Adult AMLUnited States
-
Regeneron PharmaceuticalsRecruitingRecurrent Endometrial Cancer | Recurrent Ovarian Cancer | Recurrent Fallopian Tube Cancer | Recurrent Primary Peritoneal CancerUnited States, Spain, Korea, Republic of, Italy, United Kingdom, Netherlands, Belgium, Australia, France, Israel
-
Theseus PharmaceuticalsTerminatedGastrointestinal Diseases | Neoplasms | Neoplasms, Connective and Soft Tissue | Neoplasms by Histologic Type | Gastrointestinal Neoplasms | Neoplasms, Connective Tissue | Digestive System Neoplasm | Digestive System Disease | Gastrointestinal Stromal Tumors (GIST)United States
-
Alnylam PharmaceuticalsActive, not recruitingTransthyretin Amyloidosis | Amyloidosis, HereditaryUnited States, Argentina, Australia, Belgium, Brazil, Bulgaria, Canada, Cyprus, France, Germany, Greece, Italy, Japan, Korea, Republic of, Malaysia, Mexico, Netherlands, Portugal, Spain, Sweden, Taiwan, United Kingdom
-
Concert PharmaceuticalsActive, not recruitingAlopecia AreataSpain, Germany, Poland, France, Hungary
-
Concert PharmaceuticalsEnrolling by invitationAlopecia AreataUnited States, Canada
-
Eledon PharmaceuticalsEnrolling by invitationKidney Transplant RejectionAustralia, Canada
-
Marinus PharmaceuticalsTerminated
-
Syndax PharmaceuticalsAvailable
-
Longboard PharmaceuticalsActive, not recruitingDravet Syndrome | Lennox-Gastaut Syndrome | Developmental and Epileptic EncephalopathyUnited States, Australia
-
Regeneron PharmaceuticalsTerminatedHypertriglyceridemiaUnited States, Germany, Netherlands, Canada
-
Ferring PharmaceuticalsCompletedMild-to-moderate Ulcerative ColitisPoland, Hungary, Italy, Czechia, Netherlands, Slovakia
-
Alnylam PharmaceuticalsActive, not recruitingPrimary Hyperoxaluria Type 1 | Primary HyperoxaluriaUnited States, Italy, France, Lebanon, Belgium, Netherlands, Israel, United Arab Emirates, Australia, Jordan, Turkey
-
Marinus PharmaceuticalsActive, not recruitingTuberous Sclerosis ComplexUnited States, Spain, United Kingdom, Israel, Italy, Germany, France, Canada
-
Alnylam PharmaceuticalsActive, not recruitingHypertensionUnited States, Canada, Latvia, Poland, United Kingdom, Germany, Lithuania, Estonia, Puerto Rico
-
X4 PharmaceuticalsActive, not recruiting
-
Regeneron PharmaceuticalsCompletedFamilial Partial Lipodystrophy | Metabolic AbnormalitiesUnited States, France, Spain, Turkey, United Kingdom
-
Arrowhead PharmaceuticalsActive, not recruitingHomozygous Familial HypercholesterolemiaAustralia, Canada, United States, South Africa
-
Santhera PharmaceuticalsSanthera PharmaceuticalsActive, not recruitingDuchenne Muscular DystrophyCanada
-
ASLAN PharmaceuticalsCompletedAtopic DermatitisUnited States, Australia, Singapore, India, Canada, New Zealand, Dominican Republic, Poland
-
Alnylam PharmaceuticalsCompletedAmyloid Neuropathies | Amyloid Neuropathies, Familial | TTR-mediated Amyloidosis | Amyloidosis, Hereditary | Amyloidosis, Hereditary, Transthyretin-Related | Familial Amyloid PolyneuropathiesUnited States, Canada, Argentina, Australia, Bulgaria, Cyprus, Italy, Japan, Malaysia, Mexico, Netherlands, Portugal, Spain, Sweden, Germany, France, Brazil, Turkey, Korea, Republic of, Taiwan, United Kingdom
-
Sparrow PharmaceuticalsCompletedA Study to Assess 11 Beta-hydroxysteroid Dehydrogenase Type 1 Inhibition in Adipose Tissue by SPI-62Obesity | Type 2 Diabetes Mellitus in Obese | Type2DiabetesUnited States
-
Alnylam PharmaceuticalsCompletedTTR-mediated AmyloidosisPortugal, Spain, Sweden, Brazil, United States, France, Germany
-
Arrowhead PharmaceuticalsCompletedMixed DyslipidemiaUnited States, Australia, Poland, New Zealand, Canada, Hungary
-
Vanda PharmaceuticalsCompletedBipolar I DisorderUnited States, Bulgaria, Poland
-
Arrowhead PharmaceuticalsCompletedSevere HypertriglyceridemiaUnited States, Netherlands, Australia, Canada, New Zealand, Poland, Hungary, Germany
-
Ferring PharmaceuticalsCompletedControlled Ovarian StimulationDenmark, Norway, Sweden, Switzerland
-
Azurity PharmaceuticalsCompletedAbuse PotentialUnited States
-
Intercept PharmaceuticalsActive, not recruitingPrimary Biliary CholangitisUnited States
-
Vanda PharmaceuticalsActive, not recruitingNon 24 Hour Sleep Wake DisorderFrance
-
Regeneron PharmaceuticalsActive, not recruitingHealthy VolunteersBelgium
-
Regeneron PharmaceuticalsActive, not recruiting
-
Alnylam PharmaceuticalsTerminated
-
Vanda PharmaceuticalsCompletedAutism Spectrum Disorder | Smith-Magenis Syndrome | Non-24 Hour Sleep-Wake Disorder | Circadian Rhythm Sleep DisordersUnited States
-
BioCryst PharmaceuticalsActive, not recruitingHereditary Angioedema | PediatricSpain, Austria, Canada, France, Germany, Israel, Italy, Poland, Romania, United Kingdom
-
CStone PharmaceuticalsCompletedRelapsed Small Cell Lung CancerChina
-
Constellation PharmaceuticalsCompletedSolid Tumor | Advanced Malignancies | Hematological MalignancySpain, United States, Georgia
-
Longboard PharmaceuticalsAvailableDravet Syndrome | Lennox Gastaut Syndrome | Developmental and Epileptic EncephalopathiesUnited States
-
BioCryst PharmaceuticalsTerminatedBCX9930 for Treatment of PNH in Subjects With Inadequate Response to C5 Inhibitor Therapy (REDEEM-1)Paroxysmal Nocturnal Hemoglobinuria (PNH)United Kingdom, Hungary, France, Italy, Spain